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Background 
Secondary brain tumours 
are common and we are 
seeing more of them 
The prognosis has remained dismal 
(median c. 2-3 months for all-comers) 
despite advances in treating primary 
cancers and patients are dying of brain 
metastases not with them. 
WE DO NOT UNDERSTAND  
HOW LOCALLY INVASIVE THESE 
TUMOURS ARE 
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We prospectively investigated intra- and 
inter-tumour heterogeneity in a series of 
brain metastases undergoing advanced MRI 
followed by image guided neurosurgical 
sampling from the leading edge in the 
course of resection. 
   Methods 
Pre-operative 3T MRI was obtained with 32 direction 
DTI and T1 with gadolinium.  Image guided sampling 
was performed as shown at the leading edge of the 
tumour as it was removed. Histogram analysis of 
regions of interest were matched to tissue locations. 
Growth pattern was assessed by a pathologist using a 
previously described classification and CD34, Ki67, 
necrosis and cellularity were scored semi-
automatically using NIH ImageJ software. Survival 
and brain recurrence were recorded. 
 
 
 
Conclusions 
There is significant intra-tumoral heterogeneity among brain metastases and assessment of 
the brain-tumour interface radiologically and biologically may yield more useful information 
about behaviour and prognosis than assessing the whole metastasis. 
Results 
Advanced MRI is being widely 
used in clinical practice for 
diagnosis and surgical 
planning 
The mean diffusivity (MD) values recorded at the edge of 
metastases were significantly different in distribution, 
median and mean from those at the core (Wilcoxon 
matched pairs, p=.001).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
However, there are significant rates of 
local recurrence and we have shown that 
diffusion MRI  changes at the brain-
tumour boundary can predict survival and 
recurrence, as shown below. 
Age at surgery  (median, range) 62.9 years (23.9 – 76.0) 
Gender 
Female 14 54% 
Male 12 46% 
Primary 
carcinoma 
Non-small cell 
lung  13 50% 
Breast 4 15% 
Melanoma 4 15% 
Endometrial 1 4% 
Colorectal 1 4% 
Renal 1 4% 
Other 2 8% 
Extracranial 
disease? 
Absent 18 69% 
Present 8 31% 
Controlled 
primary? 
Synchronous 
presentation 9 35% 
Yes 17 65% 
Adjuvant whole 
brain 
radiotherapy? 
No 5 19% 
Yes, 30 Gy in 10# 21 81% 
Adjuvant 
chemotherapy? 
No 13 50% 
Yes 13 50% 
   There was significantly higher necrosis (p=.026) and 
a trend to higher CD34 density at the leading edge 
versus the core. MD and the change in MD across the 
leading edge correlated with cellularity (p=-.41, 
p=0.047) but did not predict clinical outcomes nor 
pathological growth pattern. 
 
Metastases which appeared more diffusely invasive pathologically (above right H&E,Ki67) had a significantly 
lower peritumoral fractional anisotropy (FA) (p=0.039) suggesting more tract white matter disruption 
(above and left FA map). These tumours  also had more dense CD34 staining (r=-.55, p=0.041) at their 
leading edge and a trend to lower survival and more rapid intracranial recurrence. 
 
